F2 Secures $14.0M Seed

Neion Bio

At Neion Bio, we use breakthroughs in genetic engineering and stem cell biology to reinvent the entire manufacturing process for biopharmaceuticals. Our platform manufactures virtually any complex molecule with orders of magnitude superior cost, scalability, and resiliency. Biomanufacturing reinvented. Medicine, democratized.

Eledone

At Eledone, we are developing a software to automate the exchange of information between customers and suppliers in B2B sectors. Our understanding: Companies operating in B2B have a huge amount of sales administration work to do, and much of it is still done manually. Our goal: To enable our customers to be more efficient in their sales administration tasks so they can focus on higher value-added commercial work. Our vision: To automate manual data entry tasks and delegate them to our Eledone AI agent.

ChAbS (Chinese Antibody Society)

The ChAbS(华人抗体协会) is an independent non-profit, non-government global professional organization with focus upon antibody-based therapeutics. The mission of the society is to bring together industry, academics, healthcare providers, and investors to connect, communicate, and collaborate on the discovery, development, manufacturing, and marketing of therapeutic antibodies. Through its programs and services, the society serves as a nurturing platform to foster the productive interaction and networking among its members worldwide. The society, in collaboration with Oxford University Press, publishes its official journal, Antibody Therapeutics which is indexed by ESCI (IF: 4.5), PubMed and Scopus (CiteScore: 8.5).

Pogo

Pogo is the world’s first AI video interviewing platform powered by purchase-verified respondents. In under an hour, brands can find and conduct video interviews with thousands of their actual buyers – all through the Pogo app, where three million users share their complete purchase history, capturing 1 in 150 U.S. shopping trips down to the SKU.

EqualAI

EqualAI is a nonprofit organization that helps companies, policy makers, and leading institutions define and implement AI governance in support of innovation and broader AI adoption. By partnering with thought and industry leaders, EqualAI fosters AI practices that promote adoption and greater societal benefit.